Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

BORIS BAGDASARIAN

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1598758062
CMS profile
254429
Location
GLENDALE, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$6,506.08

248 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $5,735.26 238
Long term medical supply or device loan $498.50 5
Education $272.32 5

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
Novartis Pharmaceuticals Corporation $716.48 18
AstraZeneca Pharmaceuticals LP $541.63 19
Celgene Corporation $381.72 23
Janssen Biotech, Inc. $339.82 10
PFIZER INC. $313.63 18
Incyte Corporation $305.30 9
ABBVIE INC. $277.35 10
Eisai Inc. $271.09 11
Lilly USA, LLC $251.71 9
Merck Sharp & Dohme LLC $206.11 7
E.R. Squibb & Sons, L.L.C. $203.53 11
Takeda Pharmaceuticals U.S.A., Inc. $197.79 7
Astellas Pharma US Inc $178.39 12
Gilead Sciences, Inc. $166.93 6
Genentech USA, Inc. $140.89 6
TerSera Therapeutics LLC $131.78 4
Boehringer Ingelheim Pharmaceuticals, Inc. $121.31 4
Regeneron Healthcare Solutions, Inc. $111.34 3
Immunocore Limited $107.45 3
Blueprint Medicines Corporation $102.47 3
PharmaEssentia USA Corporation $99.73 4
ADC Therapeutics America, Inc. $96.80 3
Bayer Healthcare Pharmaceuticals Inc. $93.14 4
Exelixis Inc. $92.43 3
Alexion Pharmaceuticals, Inc. $89.77 3
GENZYME CORPORATION $88.21 3
EMD Serono, Inc. $85.88 3
SUN PHARMACEUTICAL INDUSTRIES INC. $79.22 3
SOBI, INC $76.07 2
ARRAY BIOPHARMA INC $74.69 3
Genmab U.S., Inc. $64.18 2
Kite Pharma, Inc. $49.28 2
JAZZ PHARMACEUTICALS INC. $44.39 2
GlaxoSmithKline, LLC. $43.82 2
Karyopharm Therapeutics Inc. $42.67 2
Apellis Pharmaceuticals, Inc. $31.76 1
SpringWorks Therapeutics, Inc. $29.86 1
Pharmacosmos Therapeutics Inc. $28.92 1
Tempus AI, Inc $28.34 2
PUMA BIOTECHNOLOGY, INC. $26.78 1
Ipsen Biopharmaceuticals, Inc $26.66 1
Daiichi Sankyo Inc. $26.26 1
TAIHO ONCOLOGY, INC. $25.21 1
Mirati Therapeutics, Inc. $20.26 1
Deciphera Pharmaceuticals Inc. $20.01 1
Fennec Pharmaceuticals, Inc. $18.65 1
Chiesi USA, Inc. $18.57 1
BeiGene USA, Inc. $17.80 1

Page 3 of 5; records 101–150 of 248 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

BORIS BAGDASARIAN

NPI 1598758062 · CMS profile ID 254429

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

GLENDALE, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 5; records 101–150 of 248 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1598758062?year=2024&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
BORIS BAGDASARIAN, NPI 1598758062, CMS profile ID 254429. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 5; records 101–150 of 248 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1598758062?year=2024&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). BORIS BAGDASARIAN, NPI 1598758062, CMS profile ID 254429. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 5; records 101–150 of 248 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1598758062?year=2024&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
BORIS BAGDASARIAN, NPI 1598758062, CMS profile ID 254429, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 5; records 101–150 of 248 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1598758062?year=2024&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

248 matching records · $6,506.08 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 248 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 248.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Kite Pharma, Inc. $23.7308/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1128614277 CMS
PFIZER INC. $25.5508/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131871441 CMS
Lilly USA, LLC $26.7208/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136071101 CMS
ABBVIE INC. $22.0408/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103263127 CMS
Incyte Corporation $29.3908/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141230925 CMS
ABBVIE INC. $30.6708/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103263125 CMS
Novartis Pharmaceuticals Corporation $21.7208/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086718337 CMS
Janssen Biotech, Inc. $27.9508/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078299421 CMS
AstraZeneca Pharmaceuticals LP $34.9008/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105476661 CMS
Merck Sharp & Dohme LLC $30.8807/31/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141854239 CMS
Celgene Corporation $31.6607/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101174930 CMS
Exelixis Inc. $27.0607/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1138556009 CMS
Gilead Sciences, Inc. $31.8507/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133642068 CMS
ARRAY BIOPHARMA INC $19.4207/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131338867 CMS
E.R. Squibb & Sons, L.L.C. $24.0407/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101701107 CMS
Merck Sharp & Dohme LLC $26.5107/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141922918 CMS
EMD Serono, Inc. $27.6707/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1120243785 CMS
PharmaEssentia USA Corporation $29.3407/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1137310302 CMS
SOBI, INC $32.9007/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141424183 CMS
Eisai Inc. $30.4707/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110733869 CMS
AstraZeneca Pharmaceuticals LP $31.3907/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104525462 CMS
Incyte Corporation $29.6807/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141264173 CMS
ABBVIE INC. $19.0406/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103263123 CMS
Bayer Healthcare Pharmaceuticals Inc. $24.5506/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086257862 CMS
ABBVIE INC. $29.2006/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103263121 CMS
Regeneron Healthcare Solutions, Inc. $38.0606/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114003351 CMS
Eisai Inc. $24.4606/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110733877 CMS
Takeda Pharmaceuticals U.S.A., Inc. $16.4006/17/2024 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1144953165 CMS
BeiGene USA, Inc. $17.8006/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1120860671 CMS
AstraZeneca Pharmaceuticals LP $19.2006/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104580070 CMS
Lilly USA, LLC $32.7806/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136083624 CMS
AstraZeneca Pharmaceuticals LP $23.4406/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104365727 CMS
E.R. Squibb & Sons, L.L.C. $14.4406/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101701100 CMS
Incyte Corporation $74.9906/06/2024 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141303745 CMS
Novartis Pharmaceuticals Corporation $23.5706/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086718327 CMS
PFIZER INC. $21.1306/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131677441 CMS
ABBVIE INC. $34.1906/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103263119 CMS
Astellas Pharma US Inc $2.8106/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139365111 CMS
Astellas Pharma US Inc $20.1606/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139365175 CMS
Janssen Biotech, Inc. $74.9906/02/2024 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078299345 CMS
Janssen Biotech, Inc. $34.8305/31/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078299257 CMS
Celgene Corporation $30.2105/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101174918 CMS
AstraZeneca Pharmaceuticals LP $34.9205/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105724377 CMS
Lilly USA, LLC $29.0105/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136073445 CMS
Alexion Pharmaceuticals, Inc. $30.9405/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1094034888 CMS
Merck Sharp & Dohme LLC $31.1605/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141854237 CMS
Deciphera Pharmaceuticals Inc. $20.0105/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145872141 CMS
ABBVIE INC. $22.9505/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103263117 CMS
Incyte Corporation $29.5905/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141238631 CMS
ABBVIE INC. $27.8005/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103263115 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $5,153.88 253
PY2020 $4,903.09 186
PY2021 $3,824.69 176
PY2022 $4,722.98 189
PY2023 $5,465.64 209
PY2024 $6,506.08 248
PY2025 $7,192.17 240

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2022 Principal investigator $8,140.00 3
PY2021 Principal investigator $21,557.00 2
PY2020 Principal investigator $2,150.70 3
PY2019 Principal investigator $2,498.00 3

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

3 records in PY2022

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Secura Bio, Inc. $2,500.00 10/20/2022 Non-covered Recipient Entity
SCORA NETWORK LLC
CLBH589D2222 No dispute reported 06/30/2026 965257059
Principal investigator 1 Novartis Pharmaceuticals Corporation $5,500.00 03/01/2022 Non-covered Recipient Entity
ADVENTIST HEALTH
A RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED STUDY OF LEE011 IN COMBINATION WITH LETROZOLE FOR THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR POSITIVE HER2 NEGATIVE ADVANCED BREAST CANCER WHO RECEIVED NO PRIOR HORMONAL THERAPY FOR ADVANCED DI No dispute reported 06/30/2026 910070379
Principal investigator 1 Novartis Pharmaceuticals Corporation $140.00 01/23/2022 Non-covered Recipient Entity
LOS ANGELES CANCER NETWORK
A PHASE II MULTICENTER THREE COHORT STUDY OF ORAL CMET INHIBITOR INC280 IN ADULT PATIENTS WITH EGFR WILD TYPE WT ADVANCED NON SMALL CELL LUNG CANCER NSCLC WHO HAVE RECEIVED ONE OR TWO PRIOR LINES OF SYSTEMIC THERAPY FORADVANCED METASTATIC DISEASE No dispute reported 06/30/2026 909403829